This observational study explored the effects of hormone replacement therapy (HRT) on inflammatory and hemostasis markers in elderly women aged 65 and older. It found that unopposed estrogen use was associated with a significant increase in C-reactive protein levels and Factor VIIc, while both unopposed estrogen and estrogen/progestin reduced plasminogen
